Prestige Consumer Healthcare Inc. (PBH) |
| 56.745 0.195 (0.34%) 04-13 12:55 |
| Open: | 56.27 |
| High: | 57 |
| Low: | 55.7854 |
| Volume: | 75,406 |
| Market Cap: | 2,729(M) |
| PE Ratio: | 14.97 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 67.00 |
| Resistance 1: | 60.99 |
| Pivot price: | 57.99 |
| Support 1: | 51.26 |
| Support 2: | 42.65 |
| 52w High: | 89.37 |
| 52w Low: | 51.24 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
| EPS | 3.790 |
| Book Value | 38.660 |
| PEG Ratio | 0.00 |
| Gross Profit | 13.290 |
| Profit Margin (%) | 16.90 |
| Operating Margin (%) | 29.10 |
| Return on Assets (ttm) | 6.1 |
| Return on Equity (ttm) | 10.3 |
Wed, 08 Apr 2026
Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio - Sahm
Mon, 06 Apr 2026
Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 32% One-Year Share Price Drop - Yahoo Finance
Mon, 30 Mar 2026
Prestige Consumer Health to acquire Breathe Right for $1.045B - MSN
Fri, 27 Mar 2026
Vanguard (PBH) amendment shows 0 shares; reporting split after Jan 12, 2026 - Stock Titan
Sat, 21 Mar 2026
Prestige Consumer Healthcare Inc. (PBH) Breathe Right - M&A Call - Slideshow (NYSE:PBH) 2026-03-21 - Seeking Alpha
Fri, 20 Mar 2026
Prestige Consumer Healthcare: Adding A Prestigious Brand (NYSE:PBH) - Seeking Alpha
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |